News Release

Representation of Black Americans in clinical trials of cardiovascular drugs

Peer-Reviewed Publication

JAMA Network

What The Study Did: Researchers investigated representation of Black Americans in clinical trials of cardiovascular drugs approved by the U.S. Food and Drug Administration between 2006 and 2020.

Authors: Jiarui Li, M.D., of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, China, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.